All data are based on the daily closing price as of October 22, 2024
h
Hyundai Bioscience
048410.KQ
12.51 USD
-0.45
-3.47%
Overview
Last close
12.51 usd
Market cap
498.10M usd
52 week high
30.24 usd
52 week low
12.16 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
74.9431
Price/Book Value
14.3605
Enterprise Value
524.22M usd
EV/Revenue
78.1926
EV/EBITDA
-64.6317
Key financials
Revenue TTM
6.70M usd
Gross Profit TTM
2.46M usd
EBITDA TTM
-5.29M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
105.70B usd
Net debt
N/A usd
About
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.